Particle-mediated delivery of cytokines for immunotherapy

Polyanhydride microparticles enhance dendritic cell antigen presentation and activation

(2011) Maria P. Torres et al.   Acta Biomaterialia

Follicular Helper CD4 T Cells (TFH)

(2011) Shane Crotty   Annual Review of Immunology

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6

(2011) Wenda Gao et al.   CELL CYCLE

Liposomal vaccine delivery systems

(2011) Malou Henriksen-Lacey et al.   Expert Opinion on Drug Delivery

Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study

(2011) F. Ohyanagi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial

(2011) Charles Butts et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

(2011) James J. Moon et al.   NATURE MATERIALS

Bio-inspired, bioengineered and biomimetic drug delivery carriers

(2011) Jin-Wook Yoo et al.   NATURE REVIEWS DRUG DISCOVERY

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

(2011) David L. Porter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases

(2011) Bret D. Ulery et al.   PLoS One

Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines

(2011) Stacey L. Demento et al.   TRENDS IN BIOTECHNOLOGY

A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer

(2010) Charles Butts et al.   Clinical Lung Cancer

TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis

(2010) S. L. Demento et al.   JOURNAL OF IMMUNOLOGY

Modulation of CD4+ T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery

(2010) Jason Park et al.   MOLECULAR PHARMACEUTICS

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

(2010) Matthias T Stephan et al.   NATURE MEDICINE

Strategies in the design of nanoparticles for therapeutic applications

(2010) Robby A. Petros et al.   NATURE REVIEWS DRUG DISCOVERY

Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer

(2009) Michael S. Sabel et al.   BREAST CANCER RESEARCH AND TREATMENT

IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments

(2009) Michelle R. Simpson-Abelson et al.   CLINICAL IMMUNOLOGY

Liposome-based cationic adjuvant formulations (CAF): Past, present, and future

(2009) Dennis Christensen et al.   JOURNAL OF LIPOSOME RESEARCH

Polymersome carriers: From self-assembly to siRNA and protein therapeutics

(2008) David A. Christian et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy

(2008) Mohamed A. Shaker et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

A Comprehensive Platform for Ex Vivo T-cell Expansion Based on Biodegradable Polymeric Artificial Antigen-presenting Cells

(2008) Erin R Steenblock et al.   MOLECULAR THERAPY